◆ Leukemia & lymphoma/Leukemia and lymphoma2026-04-01· Dasatinib
Interstitial granulomatous drug reaction associated with tyrosine kinase inhibitor dasatinib
Grant J. Riew, Mihir K. Patil, Soo Hyun Kim, Alvaro C. Laga, Rahul S. Vedula, Connie R. Shi
原始摘要（英文原文）· Original abstract
Dasatinib is a second-generation BCR::ABL1 tyrosine kinase inhibitor (TKI) used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia [1]. Dasati...